Does VALPROATE Cause Neuroleptic malignant syndrome? 156 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 156 reports of Neuroleptic malignant syndrome have been filed in association with VALPROATE (Valproate Sodium). This represents 1.0% of all adverse event reports for VALPROATE.
156
Reports of Neuroleptic malignant syndrome with VALPROATE
1.0%
of all VALPROATE reports
7
Deaths
114
Hospitalizations
How Dangerous Is Neuroleptic malignant syndrome From VALPROATE?
Of the 156 reports, 7 (4.5%) resulted in death, 114 (73.1%) required hospitalization, and 44 (28.2%) were considered life-threatening.
Is Neuroleptic malignant syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALPROATE. However, 156 reports have been filed with the FAERS database.
What Other Side Effects Does VALPROATE Cause?
Foetal exposure during pregnancy (1,982)
Drug ineffective (1,268)
Seizure (1,083)
Epilepsy (878)
Somnolence (843)
Off label use (744)
Drug abuse (705)
Sopor (577)
Dysmorphism (552)
Drug interaction (513)
What Other Drugs Cause Neuroleptic malignant syndrome?
QUETIAPINE (1,756)
OLANZAPINE (1,748)
RISPERIDONE (1,258)
HALOPERIDOL (1,244)
ARIPIPRAZOLE (1,138)
CLOZAPINE (899)
LITHIUM (506)
LORAZEPAM (437)
PALIPERIDONE (355)
VALPROIC ACID (352)
Which VALPROATE Alternatives Have Lower Neuroleptic malignant syndrome Risk?
VALPROATE vs VALPROIC ACID
VALPROATE vs VALPROMIDE
VALPROATE vs VALSARTAN
VALPROATE vs VALTREX
VALPROATE vs VAMOROLONE